STACEY HESS: Open Payments
NPI 1508623778 · CLARINDA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 33 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $246 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $182 |
| Vanda Pharmaceuticals Inc. | 4 | $125 |
| ABBVIE INC. | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Alkermes, Inc. | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
Products named: UZEDY, FANAPT, VRAYLAR, AUSTEDO XR, Auvelity, INVEGA SUSTENNA, CAPLYTA, HETLIOZ.
Industry payments across IA — which companies pay providers there.
